Clinical Trial Update: Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating methods of oxygen delivery and their effect on transcutaneous PaCO2 was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Lung Diseases, Obstructive | Phase 2, Phase 3 | Status: TERMINATED